Reaction

Breast Microcalcification reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 120 reports · 5 co-occurring drugs

As of the last recalculation, Breast Microcalcification appears in 120 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE (PRR 208.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Conjugated Estrogens And Medroxyprogesterone Acetate	23	208.9	209.1
Raloxifene Hydrochloride	10	129.5	129.6
Conjugated Estrogens	30	118.7	118.7
Estrogens, Conjugated	30	116.5	116.6
Medroxyprogesterone Acetate	26	115.3	115.3

Related reactions

Drug Ineffective
Off Label Use
Death
Nausea
Fatigue

Data source: openFDA FAERS. See the OpenPV methodology and limitations.